Acrivon Therapeutics (ACRV) Assets (2021 - 2026)
Acrivon Therapeutics' Assets came in at $99.09 million for Q2 2026, down 37.5% from $158.58 million a year earlier and down 8.1% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Acrivon Therapeutics' Assets was $129.72 million, down 34.0% from FY2024.
- Assets carries a four-year compound annual growth rate of 5.0% (FY2021 to FY2025).
- Going back by year, Assets was $196.59 million in FY2024 (+42.2%), $138.27 million in FY2023 (-23.7%), $181.23 million in FY2022 (+70.0%) and $106.59 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Assets since Q3 2022.
- Year-over-year, Assets has declined for five consecutive quarters, with an average decline of 5.4% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q3 2023 (growth of 72.3%), and the weakest in Q1 2026 (a decline of 38.9%).
- Business Quant data shows ACRV's Assets at $107.83 million (Q1 2026), $129.72 million (Q4 2025) and $145.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Acrivon Therapeutics | 88.27 Mn | 88.27 Mn | - | 99.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.09 Mn |
| Mar 31, 2026 | 107.83 Mn |
| Dec 31, 2025 | 129.72 Mn |
| Sep 30, 2025 | 145.30 Mn |
| Jun 30, 2025 | 158.58 Mn |
| Mar 31, 2025 | 176.35 Mn |
| Dec 31, 2024 | 196.59 Mn |
| Sep 30, 2024 | 214.68 Mn |
| Jun 30, 2024 | 230.59 Mn |
| Mar 31, 2024 | 120.52 Mn |
| Dec 31, 2023 | 138.27 Mn |
| Sep 30, 2023 | 151.09 Mn |
| Jun 30, 2023 | 160.05 Mn |
| Mar 31, 2023 | 170.20 Mn |
| Dec 31, 2022 | 181.23 Mn |
| Sep 30, 2022 | 87.71 Mn |
| Dec 31, 2021 | 106.59 Mn |
API Access
Acrivon Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();